A comparison of clinically relevant sources of mesenchymal stem cell-derived exosomes: Bone marrow and amniotic fluid

Comparative study of exosomes derived from bone marrow and amniotic fluid mesenchymal stem cells for potential cell-free therapeutic applications in perinatal and pediatric diseases. Amniotic fluid MSCs yielded 25% more exosomes than bone marrow MSCs with comparable surface marker expression, suggesting amniotic fluid may be a superior source for exosome-based therapies.